trending Market Intelligence /marketintelligence/en/news-insights/trending/6gf6xyppECe1xDgV-GeHDA2 content esgSubNav
In This List

Medical Developments director retires

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Medical Developments director retires

Australia's Medical Developments International Ltd announced the retirement of nonexecutive director Allan McCallum on Dec. 17.

McCallum joined the company's board in 2003.

He is chairman of Tassal Group Ltd. and Cann Group Ltd.

Medical Developments International manufactures pharmaceutical drugs, and medical and veterinary equipment in Australia and internationally.